NCT00055250View on ClinicalTrials.gov

A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

October 31, 2005

Conditions

Pancreatic Cancer

Interventions

DRUG

Gemcitabine

DRUG

LY293111

DRUG

placebo

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5pm Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Lakeland

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00055250 - A Study With LY293111, Gemcitabine and Placebo in Patients With Pancreatic Cancer | Biotech Hunter | Biotech Hunter